Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakub Mlost

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Frontiers in Pain Research (Lausanne, Switzerland)|November 6, 2023
Editorial: Computational methods for pain pharmacologyJakub Mlost, Mateusz Kucharczyk
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Computational Approach Reveals Pronociceptive Potential of Cannabidiol in Osteoarthritis: Role of Transient Receptor Potential ChannelsJakub Mlost, Marta Kędziora, Katarzyna Starowicz
International Journal of Molecular Sciences|November 26, 2020
Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of ActionJakub Mlost, Marta Bryk, Katarzyna Starowicz
Pharmacological Research|March 5, 2019
Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic painJakub Mlost, Agnieszka Wąsik, Katarzyna Starowicz
Molecular Psychiatry|May 15, 2026
Effects of SSRIs on the spatial transcriptome of dorsal raphe serotonin neuronsCharlotta Henningson, Jakub Mlost, Iskra Pollak Dorocic
International Journal of Molecular Sciences|January 25, 2018
Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in OsteoarthritisJakub Mlost, Magdalena Kostrzewa, Natalia Malek, et al.
Neuropharmacology|December 2, 2021
Antinociceptive and chondroprotective effects of prolonged β-caryophyllene treatment in the animal model of osteoarthritis: Focus on tolerance developmentJakub Mlost, Przemysław Kac, Marta Kędziora, et al.
Frontiers in Pharmacology|May 17, 2021
Sodium Monoiodoacetate Dose-Dependent Changes in Matrix Metalloproteinases and Inflammatory Components as Prognostic Factors for the Progression of OsteoarthritisMarta Bryk, Jakub Chwastek, Jakub Mlost, et al.
Molecular Neurobiology|September 21, 2023
Description of Novel Molecular Factors in Lumbar DRGs and Spinal Cord Factors Underlying Development of Neuropathic Pain Component in the Animal Model of OsteoarthritisNatalia Malek, Jakub Mlost, Magdalena Kostrzewa, et al.
British Journal of Pharmacology|May 24, 2021
Mesenchymal stem cells and extracellular vesicles for the treatment of pain: Current status and perspectivesMarta Bryk, Elżbieta Karnas, Jakub Mlost, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Frontiers in Pain Research (Lausanne, Switzerland)|November 6, 2023
Editorial: Computational methods for pain pharmacologyJakub Mlost, Mateusz Kucharczyk
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Computational Approach Reveals Pronociceptive Potential of Cannabidiol in Osteoarthritis: Role of Transient Receptor Potential ChannelsJakub Mlost, Marta Kędziora, Katarzyna Starowicz
International Journal of Molecular Sciences|November 26, 2020
Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of ActionJakub Mlost, Marta Bryk, Katarzyna Starowicz
Pharmacological Research|March 5, 2019
Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic painJakub Mlost, Agnieszka Wąsik, Katarzyna Starowicz
Molecular Psychiatry|May 15, 2026
Effects of SSRIs on the spatial transcriptome of dorsal raphe serotonin neuronsCharlotta Henningson, Jakub Mlost, Iskra Pollak Dorocic
International Journal of Molecular Sciences|January 25, 2018
Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in OsteoarthritisJakub Mlost, Magdalena Kostrzewa, Natalia Malek, et al.
Neuropharmacology|December 2, 2021
Antinociceptive and chondroprotective effects of prolonged β-caryophyllene treatment in the animal model of osteoarthritis: Focus on tolerance developmentJakub Mlost, Przemysław Kac, Marta Kędziora, et al.
Frontiers in Pharmacology|May 17, 2021
Sodium Monoiodoacetate Dose-Dependent Changes in Matrix Metalloproteinases and Inflammatory Components as Prognostic Factors for the Progression of OsteoarthritisMarta Bryk, Jakub Chwastek, Jakub Mlost, et al.
Molecular Neurobiology|September 21, 2023
Description of Novel Molecular Factors in Lumbar DRGs and Spinal Cord Factors Underlying Development of Neuropathic Pain Component in the Animal Model of OsteoarthritisNatalia Malek, Jakub Mlost, Magdalena Kostrzewa, et al.
British Journal of Pharmacology|May 24, 2021
Mesenchymal stem cells and extracellular vesicles for the treatment of pain: Current status and perspectivesMarta Bryk, Elżbieta Karnas, Jakub Mlost, et al.
Pageof 2